In this study, we found that 341 out of 779 (43.8%) subjects with insulin-treated type 2 diabetes presented with hyperinsulinemia, of whom 113 subjects (33.1%) had real hyperinsulinemia, and the remaining subjects (66.9%) were IAs-positive. The gene discussed is INS; the disease is Hyperinsulinemia.